midazolam has been researched along with Developmental Psychomotor Disorders in 4 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The benzodiazepine midazolam (MDZ) is commonly used as first-line treatment in patients with acute seizures." | 5.12 | Clinical pharmacokinetic and pharmacodynamic profile of midazolam nasal spray. ( Bouw, MR; Chung, SS; Gidal, B; King, A; Tomasovic, J; Van Ess, PJ; Wheless, JW, 2021) |
| "Midazolam was also associated with significant anterograde amnesia, both postoperatively and at 48 h, for information presented in the interval between premedication and surgery." | 2.73 | A randomised placebo-controlled trial of the effects of midazolam premedication on children's postoperative cognition. ( Asbury, AJ; Bowman, AW; Hosey, MT; Martin, K; Millar, K; Musiello, T; Welbury, RR, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouw, MR | 1 |
| Chung, SS | 1 |
| Gidal, B | 1 |
| King, A | 1 |
| Tomasovic, J | 1 |
| Wheless, JW | 1 |
| Van Ess, PJ | 1 |
| Fujikawa, Y | 1 |
| Sugai, K | 1 |
| Hanaoka, S | 1 |
| Fukumizu, M | 1 |
| Sasaki, M | 1 |
| Kaga, M | 1 |
| Boylan, GB | 1 |
| Rennie, JM | 1 |
| Chorley, G | 1 |
| Pressler, RM | 1 |
| Fox, GF | 1 |
| Farrer, K | 1 |
| Morton, M | 1 |
| Binnie, CD | 1 |
| Millar, K | 1 |
| Asbury, AJ | 1 |
| Bowman, AW | 1 |
| Hosey, MT | 1 |
| Martin, K | 1 |
| Musiello, T | 1 |
| Welbury, RR | 1 |
1 review available for midazolam and Developmental Psychomotor Disorders
| Article | Year |
|---|---|
Clinical pharmacokinetic and pharmacodynamic profile of midazolam nasal spray.
Topics: Child; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Humans; Midazolam; Nasal Sprays; P | 2021 |
2 trials available for midazolam and Developmental Psychomotor Disorders
| Article | Year |
|---|---|
Second-line anticonvulsant treatment of neonatal seizures: a video-EEG monitoring study.
Topics: Anticonvulsants; Clonazepam; Drug Resistance; Electroencephalography; Epilepsy; Female; Humans; Infa | 2004 |
A randomised placebo-controlled trial of the effects of midazolam premedication on children's postoperative cognition.
Topics: Anesthesia, General; Anti-Anxiety Agents; Child; Child, Preschool; Cognition Disorders; Female; Huma | 2007 |
1 other study available for midazolam and Developmental Psychomotor Disorders
| Article | Year |
|---|---|
[Three cases with severe motor and intellectual disabilities presenting the severest condition caused by prolonged non-convulsive status epilepticus].
Topics: Child, Preschool; Disabled Children; Disease Progression; Electroencephalography; Female; Humans; In | 2003 |